# Amit Technion

> Amit Technion is a VC fund backing Medical, mHealth and Software. See 2 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Aug 2020
- Lead investor: 0%
- Last updated: Sep 2026
- Website: http://www.amitechnion.com/Mann

Amit Technion is an acceleration hub that supports the development and commercialization of biomedical innovations conceived by Technion students, faculty, and alumni. It aspires to bridge the gap between applied academic research and commercial success. The firm was established in 2006 by Dr. Alfred E. Mann and by the Technion.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| mHealth | 1 | 50% |
| Software | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Voiceitt | Voiceitt is an automatic speech recognition technology platform. Voiceitt provides a new dimension of independence and quality of life for people with speech and motor disabilities, and a useful tool for those who care for and about them. | $10M | Series A | Aug 11, 2020 | http://www.voiceitt.com/ |
| Colospan | Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and diverting colonic stomas. It has developed a product that protects the intestine after a colectomy and sealing of the intestine, which is performed in cases of severe intestinal inflammatory disease andcancer of the bowel or rectum. In places where the intestine has been sealed, leakage requiring prolonged hospitalization or repeat surgery on already weak patients is liable to occur. The company develops a device that prevents inner-body leaks after intestinal surgery. It also develops a silicone-based, tube-like device intended to prevent the leak of feces into the body cavity after surgery in the intestines or colon. Colospan's device is meant to prevent or delay the for need colostomy—the surgical creation of an external bypass for the intestine or colon following the removal of a diseased part. The company’s lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site.Colospan was founded in 2010 and is based in Kefar Sava, Israel. | $8M | Venture - Series Unknown | Oct 01, 2017 | http://colospan.com/ |

2 of 2 investments shown.

## Co-investors
- [AARP](https://shizune.co/investors/profile/aarp) — VC Fund, 1 deal together
- Cahn Capital — VC Fund, 1 deal together
- [Clal Biotechnology Industries](https://shizune.co/investors/profile/clal-biotechnology) — VC Fund, 1 deal together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 1 deal together
- [Docor International Management](https://shizune.co/investors/profile/docor-international-management) — VC Fund, 1 deal together
- [Dreamit Ventures](https://shizune.co/investors/profile/dreamit-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Amit Technion invest in?

Amit Technion invests primarily in Medical, mHealth and Software startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Amit Technion last invest?

The most recent investment recorded for Amit Technion closed in Aug 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co